Precision Medicine

Can AI Revolutionize Lung Cancer Care Through Data?
Tech & Innovation Can AI Revolutionize Lung Cancer Care Through Data?

The shift toward precision medicine requires a continuous assessment of risk that updates dynamically as new follow-up scans and blood tests become available. This ongoing demand for agility is driving a fundamental transformation in lung cancer management, moving the field away from isolated

Synthetic Protein Engineering – Review
Tech & Innovation Synthetic Protein Engineering – Review

The biological monopoly held by the standard twenty amino acids has finally met its match in a laboratory environment that prioritizes chemical versatility over the stubborn requirements of cellular survival. For decades, the progress of synthetic biology was tethered to the growth cycles and

Soap-Bubble-Inspired Artificial Lung Mimics Human Breathing
Biotech & Bioprocessing Soap-Bubble-Inspired Artificial Lung Mimics Human Breathing

Respiratory motion is not just a byproduct of breathing but a fundamental driver of how the human immune system responds to viral threats. For decades, the medical community struggled to understand why laboratory experiments involving lung infections often failed to match the complex reality of a

UC Davis Cancer Center Renews Prestigious NCI Designation
Research & Development UC Davis Cancer Center Renews Prestigious NCI Designation

In addition to the recent NCI renewal, the UC Davis Medical Center has maintained its ranking as the top hospital in the Sacramento area for fifteen consecutive years according to national reports. This sustained excellence reached a new milestone today as the National Cancer Institute officially

NuVasc Pioneers Precision Medicine for Brain Malformations
Tech & Innovation NuVasc Pioneers Precision Medicine for Brain Malformations

Current medical protocols often leave patients with complex brain malformations in a state of uncertainty while waiting for potential vessel ruptures. This reactive stance stems from the inherent risks associated with invasive surgery and the limitations of traditional imaging, which frequently

Can a Common Drug Prevent Triple-Negative Breast Cancer?
Research & Development Can a Common Drug Prevent Triple-Negative Breast Cancer?

When levels of miR-342 drop, the E2F genetic pathway is unleashed, signaling disseminated cancer cells to begin the rapid multiplication required to form tumors. This mechanism serves as a terrifying catalyst for triple-negative breast cancer, a subtype that has historically defied the precision

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later